US Bancorp’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.97K Sell
1,147
-44,648
-97% -$76.8K ﹤0.01% 3866
2025
Q1
$152K Buy
45,795
+33,298
+266% +$111K ﹤0.01% 2162
2024
Q4
$92.5K Sell
12,497
-7,158
-36% -$53K ﹤0.01% 2439
2024
Q3
$185K Sell
19,655
-8,803
-31% -$82.7K ﹤0.01% 2077
2024
Q2
$228K Sell
28,458
-3,099
-10% -$24.9K ﹤0.01% 1927
2024
Q1
$468K Buy
31,557
+16,800
+114% +$249K ﹤0.01% 1539
2023
Q4
$120K Buy
14,757
+10,170
+222% +$82.7K ﹤0.01% 2261
2023
Q3
$20.9K Sell
4,587
-910
-17% -$4.14K ﹤0.01% 2855
2023
Q2
$38.7K Sell
5,497
-94
-2% -$662 ﹤0.01% 2604
2023
Q1
$34.2K Buy
5,591
+2,354
+73% +$14.4K ﹤0.01% 2707
2022
Q4
$20.7K Buy
3,237
+730
+29% +$4.67K ﹤0.01% 2968
2022
Q3
$24K Sell
2,507
-1,492
-37% -$14.3K ﹤0.01% 2927
2022
Q2
$44K Buy
3,999
+726
+22% +$7.99K ﹤0.01% 2644
2022
Q1
$54K Sell
3,273
-1,035
-24% -$17.1K ﹤0.01% 2573
2021
Q4
$82K Sell
4,308
-4,181
-49% -$79.6K ﹤0.01% 2382
2021
Q3
$209K Buy
8,489
+2,767
+48% +$68.1K ﹤0.01% 1942
2021
Q2
$150K Buy
5,722
+1,410
+33% +$37K ﹤0.01% 2094
2021
Q1
$136K Sell
4,312
-16,461
-79% -$519K ﹤0.01% 2103
2020
Q4
$964K Buy
20,773
+8,025
+63% +$372K ﹤0.01% 1121
2020
Q3
$420K Buy
12,748
+9,158
+255% +$302K ﹤0.01% 1413
2020
Q2
$99K Sell
3,590
-98
-3% -$2.7K ﹤0.01% 2094
2020
Q1
$110K Buy
3,688
+1,577
+75% +$47K ﹤0.01% 1941
2019
Q4
$58K Buy
2,111
+886
+72% +$24.3K ﹤0.01% 2396
2019
Q3
$23K Buy
1,225
+294
+32% +$5.52K ﹤0.01% 2781
2019
Q2
$23K Buy
+931
New +$23K ﹤0.01% 2823
2016
Q1
Sell
-7,206
Closed -$55K 3595
2015
Q4
$55K Buy
7,206
+437
+6% +$3.34K ﹤0.01% 2396
2015
Q3
$39K Buy
+6,769
New +$39K ﹤0.01% 2579
2015
Q2
Sell
-7,920
Closed -$96K 3597
2015
Q1
$96K Buy
+7,920
New +$96K ﹤0.01% 2180